http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김지원(Jiwon Kim),이준녕(Jun Nyung Lee),하윤석(Yun-Sok Ha),권태균(Tae Gyun Kwon),이상규(Sangkyu Lee) 대한약학회 2020 약학회지 Vol.64 No.4
Prostate cancer is one of the most common male cancer. It tends to be known as “mild cancer” due to its high five-year survival rate. However, some patients develop castration-resistant prostate cancer (CRPC) during androgen deprivation therapy (ADT) treatment, with high metastasis and poor prognosis. In addition to conventional ADT treatments, specific treatments are implemented for CRPC. There are four second-generation anti-androgen drugs, taxane chemotherapy, and immunotherapy using vaccines and monoclonal antibodies. This review paper outlines the mechanism of prostate cancer leading to CRPC and reviews the standard treatment of CRPC. It also summarized the trends of anticancer drugs under clinical trials to obtain CRPC as an additional indication.
Kyong Min Park(박경민),Jae-Wook Chung(정재욱),Jun-Koo Kang(강준구),Teak Jun Shin(신택준),Se Yun Kwon(권세윤),Hyun Chan Jang(장현찬),Yun-Sok Ha(하윤석),Seock Hwan Choi(최석환),Wonho Jung(정원호),Jun Nyung Lee(이준녕),Byung Hoon Kim 대한비뇨기종양학회 2020 대한비뇨기종양학회지 Vol.18 No.1
Purpose: The aim of this study was to analyze the perioperative complications and oncological outcomes of radical prostatectomy (RP) in patients who underwent multiple prostate biopsies. Materials and Methods: A total of 1,112 patients who underwent RP between January 2009 and April 2016 at 4 different centers were included in this study. We divided these patients into 2 groups: patients who underwent only 1st biopsy, and those who underwent 2nd or more repeated biopsies. The association between the number of prior biopsies and perioperative complications and biochemical recurrence (BCR) was analyzed. Results: Of 1,112 patients, 1,046 patients (94.1%) underwent only 1st biopsy, and 66 (5.9%) underwent 2nd or more repeated biopsies. There were no significant differences in preoperative prostate-specific antigen levels, operation times, blood loss volumes, or hospital stay durations (all p>0.05). Patients who underwent multiple prostate biopsies presented with a localized tumor significantly more often (p<0.05). The Gleason score and rate of positive surgical margins were significantly lower in patients with multiple biopsies (all p<0.05). The Cox proportional hazards model analysis indicated that there was no association between the number of prior prostate biopsies and BCR (p>0.05). Kaplan-Meier curve analysis indicated that BCR-free survival rates between the 2 groups were similar (p>0.05). Conclusions: Multiple prostate biopsies are not associated with an increased risk of perioperative complications, adverse pathological outcomes, or higher rates of BCR in patients who have undergone RP.